Camp4 Therapeutics Corporation (CAMP)

Camp4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	2.53	38.38	83.19
Cash & Short-Term Investments	2.53	38.38	83.19
Cash Growth	-96.96%	-53.86%	-
Other Receivables	0.11	0.44	0.68
Receivables	1.11	0.44	0.68
Prepaid Expenses	-	0.29	0.16
Other Current Assets	1.87	0.9	0.38
Total Current Assets	5.5	40.01	84.41
Property, Plant & Equipment	10.91	13.31	16.79
Other Long-Term Assets	1.62	1.62	1.35
Total Assets	21.36	54.95	102.55
Accounts Payable	3.87	1.04	2.15
Accrued Expenses	3.68	3.01	3.17
Current Portion of Long-Term Debt	0.19	0.41	-
Current Portion of Leases	3.09	3.06	2.37
Other Current Liabilities	-	0.29	0.26
Total Current Liabilities	11.83	7.81	7.95
Long-Term Debt	-	0.09	-
Long-Term Leases	6.36	8.64	10.03
Other Long-Term Liabilities	0	0	-0.04
Total Liabilities	18.19	16.53	17.93
Common Stock	0	0	0
Additional Paid-In Capital	39.5	36.23	33.14
Retained Earnings	-198.47	-159.96	-110.67
Total Common Equity	-158.98	-123.73	-77.53
Shareholders' Equity	3.17	38.42	84.62
Total Liabilities & Equity	21.36	54.95	102.55
Total Debt	9.64	12.18	12.4
Net Cash (Debt)	-7.11	26.2	70.8
Net Cash Growth	-	-63.00%	-
Net Cash Per Share	-14.67	66.33	226.69
Filing Date Shares Outstanding	20.16	0.46	0.31
Total Common Shares Outstanding	1.01	0.46	0.31
Working Capital	-6.33	32.21	76.46
Book Value Per Share	-158.04	-268.57	-248.26
Tangible Book Value	-158.98	-123.73	-77.53
Tangible Book Value Per Share	-158.04	-268.57	-248.26
Machinery	4.95	4.78	4.17
Leasehold Improvements	4.52	4.52	4.52

Source: S&P Capital IQ. Standard template. Financial Sources.